EUVIMEDEUVIMED entdecken
Crossref

Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn

Xueni Chen, Aihong Jiang, Yajuan Yu, Yulin Chen

Clinical Laboratory · 2026 · 72 (06/2026)

DOI: 10.7754/clin.lab.2025.250767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Xueni Chen und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythroblastosis, FetalHumansFemalePregnancyInfant, NewbornRetrospective StudiesAdultSeverity of Illness IndexIsoantibodies

Substanzen

Isoantibodies

Zitieren

APA

Chen, X., Jiang, A., Yu, Y., & Chen, Y. (2026). Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn. Clinical Laboratory, 72(06/2026). https://doi.org/10.7754/clin.lab.2025.250767

Vancouver

Chen X, Jiang A, Yu Y, Chen Y. Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn. Clinical Laboratory. 2026;72(06/2026). doi:10.7754/clin.lab.2025.250767

BibTeX
@article{Chen2026,
  author = {Chen, Xueni and Jiang, Aihong and Yu, Yajuan and Chen, Yulin},
  title = {Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn},
  journal = {Clinical Laboratory},
  year = {2026},
  volume = {72},
  number = {06/2026},
  doi = {10.7754/clin.lab.2025.250767}
}
Kostenlos starten →